Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Reimherr

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Psychopharmacology|April 1, 1988
Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depressionW F Byerley, F W Reimherr, D R Wood, et al.
Psychopharmacology Bulletin|January 1, 1984
Characteristics of responders to fluoxetineF W Reimherr, D R Wood, B Byerley, et al.
Psychopharmacology Bulletin|January 1, 1996
An open trial of nefazodone in adult patients with generalized anxiety disorderD W Hedges, F W Reimherr, R E Strong, et al.
Clinical Therapeutics|July 15, 1998
A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatientsF W Reimherr, L A Cunningham, S R Batey, et al.
Psychopharmacology Bulletin|January 1, 1988
Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorderF W Reimherr, W F Byerley, M F Ward, et al.
The Journal of Clinical Psychiatry|October 16, 2001
Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depressionF W Reimherr, R E Strong, B K Marchant, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Blood pressure changes during short-term fluoxetine treatmentJ D Amsterdam, F Garcia-Espana, J Fawcett, et al.
Journal of Clinical Psychopharmacology|January 5, 2002
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapyD J Brunswick, J D Amsterdam, J Fawcett, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Efficacy and safety of fluoxetine in treating bipolar II major depressive episodeJ D Amsterdam, F Garcia-España, J Fawcett, et al.
The American Journal of Psychiatry|July 1, 1997
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter studyJ D Amsterdam, J Fawcett, F M Quitkin, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Psychopharmacology|April 1, 1988
Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depressionW F Byerley, F W Reimherr, D R Wood, et al.
Psychopharmacology Bulletin|January 1, 1984
Characteristics of responders to fluoxetineF W Reimherr, D R Wood, B Byerley, et al.
Psychopharmacology Bulletin|January 1, 1996
An open trial of nefazodone in adult patients with generalized anxiety disorderD W Hedges, F W Reimherr, R E Strong, et al.
Clinical Therapeutics|July 15, 1998
A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatientsF W Reimherr, L A Cunningham, S R Batey, et al.
Psychopharmacology Bulletin|January 1, 1988
Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorderF W Reimherr, W F Byerley, M F Ward, et al.
The Journal of Clinical Psychiatry|October 16, 2001
Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depressionF W Reimherr, R E Strong, B K Marchant, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Blood pressure changes during short-term fluoxetine treatmentJ D Amsterdam, F Garcia-Espana, J Fawcett, et al.
Journal of Clinical Psychopharmacology|January 5, 2002
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapyD J Brunswick, J D Amsterdam, J Fawcett, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Efficacy and safety of fluoxetine in treating bipolar II major depressive episodeJ D Amsterdam, F Garcia-España, J Fawcett, et al.
The American Journal of Psychiatry|July 1, 1997
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter studyJ D Amsterdam, J Fawcett, F M Quitkin, et al.
Pageof 4